Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Commission File Number: 001-39100 Progyny, Inc. (Exact name of registrant as specified in its chart ...

Progyny, Inc. (NASDAQ:PGNY) Q1 2020 Earnings Conference Call May 12, 2020 4:45 PM ET Company Participants James Hart - Vice President, Investor Relations David Schlanger - Chief Executive Officer Pete Anevski - President, Chief Financial Officer and Chief Operating Officer Conference Call Participants Sarah James - Piper Sandler Anne Samuel - JP Morgan Michael Cherny - Bank of America Ralph Jacoby - Citi Operator Good afternoon, and welcome to the Progyny Inc. First Quarter 2020 Earnings Conference Call. Al ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Commission File Number: 001-39100 Progyny, Inc. (Exact name of registrant as specified in its charter) WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ D ...

Progyny, Inc. (NASDAQ:PGNY) Q4 2019 Results Conference Call March 5, 2019 4:45 PM ET Company Participants James Hart - IR David Schlanger - CEO Pete Anevski - President, CFO and COO Conference Call Participants Anne Samuel - JP Morgan Michael Cherny - Bank of America Sarah James - Piper Sandler Ralph Jacoby - Citi Operator Good afternoon, and welcome to the Progyny Inc. Fourth Quarter 2019 Earnings Conference Call. All participants will be in a listen only mode [Operator Instructions]. After today's present ...

| --- | --- | --- | |-------|-------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | | | | | | | P R O P R I E T A R Y & C O N F I D E N T I AL \| N O T F O R D I S T R I B U T I O N JP Morgan 38th Annual Healthcare Conference: Progyny Overview David Schlanger, CEO 01.13.20 | | | | | This presentation includes forward-looking statements made pursuant to the safe ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Commission File Number: 001-39100 Progyny, Inc. (Exact name of registrant as specified in its c ...

Progyny, Inc. (NASDAQ:PGNY) Q3 2019 Results Conference Call December 4, 2019 5:00 PM ET Company Participants James Hart - Vice President of Investor Relations David Schlanger - CEO Pete Anevski - President CFO and COO Conference Call Participants Anne Samuel - J.P. Morgan Sarah James - Piper Jaffray Michael Cherny - Bank of America Merrill Lynch Steve Tanal - Goldman Sachs Daniel Grosslight - SVB Leerink Operator Good day. And welcome to the Third Quarter 2019 Earnings Conference Call for Progyny. All parti ...